Figure 2.
Gene mutation spectrum detected by next-generation target sequencing. (A) Gene mutation rate in MG-positive and MG-negative patients with CLL. (B) Mutation rates in patients with different types of paraproteinemia. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001.

Gene mutation spectrum detected by next-generation target sequencing. (A) Gene mutation rate in MG-positive and MG-negative patients with CLL. (B) Mutation rates in patients with different types of paraproteinemia. ∗P < .05; ∗∗P < .01; ∗∗∗P < .001.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal